Nothing Special   »   [go: up one dir, main page]

DK2185937T4 - Fremgangsmåde til at bestemme sepsis hos mennesker - Google Patents

Fremgangsmåde til at bestemme sepsis hos mennesker

Info

Publication number
DK2185937T4
DK2185937T4 DK08801791.8T DK08801791T DK2185937T4 DK 2185937 T4 DK2185937 T4 DK 2185937T4 DK 08801791 T DK08801791 T DK 08801791T DK 2185937 T4 DK2185937 T4 DK 2185937T4
Authority
DK
Denmark
Prior art keywords
humans
sepsis
procedure
psp
serum
Prior art date
Application number
DK08801791.8T
Other languages
English (en)
Other versions
DK2185937T3 (da
Inventor
Rolf Graf
Daniel Bimmler
Marius Keel
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40040164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2185937(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Zuerich filed Critical Univ Zuerich
Application granted granted Critical
Publication of DK2185937T3 publication Critical patent/DK2185937T3/da
Publication of DK2185937T4 publication Critical patent/DK2185937T4/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/474Pancreatic thread protein; Reg protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/26Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK08801791.8T 2007-09-07 2008-09-02 Fremgangsmåde til at bestemme sepsis hos mennesker DK2185937T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (2)

Publication Number Publication Date
DK2185937T3 DK2185937T3 (da) 2011-09-12
DK2185937T4 true DK2185937T4 (da) 2014-10-20

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08801791.8T DK2185937T4 (da) 2007-09-07 2008-09-02 Fremgangsmåde til at bestemme sepsis hos mennesker

Country Status (13)

Country Link
US (2) US8435755B2 (da)
EP (1) EP2185937B2 (da)
JP (1) JP5048838B2 (da)
CN (1) CN101796418B (da)
AT (1) ATE514950T1 (da)
AU (1) AU2008295046B2 (da)
CA (1) CA2696319C (da)
DK (1) DK2185937T4 (da)
ES (1) ES2368877T5 (da)
NZ (1) NZ583474A (da)
PL (1) PL2185937T5 (da)
PT (1) PT2185937E (da)
WO (1) WO2009030456A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2577316B1 (en) * 2010-05-31 2017-02-08 University Hospital of Basel Method for assaying lower respiratory tract infection or inflammation
EP2612152B1 (en) 2010-08-31 2020-06-10 Otto-von-Guericke-Universität Magdeburg Method to diagnose infectious peritonitis and predict the severity and outcome thereof in humans.
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
US20140120174A1 (en) * 2012-10-30 2014-05-01 Lascco, Sa Methods of prognosis and diagnosis of sepsis
US20150362509A1 (en) * 2013-01-28 2015-12-17 Vanderbilt University Method for Differentiating Sepsis and Systemic Inflammatory Response Syndrome (SIRS)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
WO2019053118A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh PROADRÉNOMÉDULLINE AS A MARKER OF ABNORMAL PLATELET RATES
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) * 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378924B1 (en) 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
GB9613629D0 (en) * 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
ATE272215T1 (de) * 2001-12-04 2004-08-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
ATE282831T1 (de) * 2001-12-04 2004-12-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
EP1318402B1 (de) * 2001-12-04 2005-04-20 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
EP1318403B1 (de) * 2001-12-04 2004-07-28 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
AU2004203749A1 (en) * 2003-01-06 2004-07-22 Wyeth Compositions and methods for diagnosing and treating colon cancers
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) * 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
EP2577316B1 (en) * 2010-05-31 2017-02-08 University Hospital of Basel Method for assaying lower respiratory tract infection or inflammation

Also Published As

Publication number Publication date
AU2008295046B2 (en) 2013-08-01
CA2696319A1 (en) 2009-03-12
US20100222223A1 (en) 2010-09-02
ES2368877T5 (es) 2014-10-20
NZ583474A (en) 2011-07-29
EP2185937B2 (en) 2014-07-16
DK2185937T3 (da) 2011-09-12
US9857381B2 (en) 2018-01-02
EP2185937B1 (en) 2011-06-29
ES2368877T3 (es) 2011-11-23
PL2185937T5 (pl) 2014-12-31
PT2185937E (pt) 2011-09-06
US20130203612A1 (en) 2013-08-08
CN101796418A (zh) 2010-08-04
CN101796418B (zh) 2013-05-01
PL2185937T3 (pl) 2012-02-29
CA2696319C (en) 2021-02-02
EP2185937A1 (en) 2010-05-19
JP2010538282A (ja) 2010-12-09
WO2009030456A1 (en) 2009-03-12
JP5048838B2 (ja) 2012-10-17
ATE514950T1 (de) 2011-07-15
US8435755B2 (en) 2013-05-07
AU2008295046A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
DK2185937T4 (da) Fremgangsmåde til at bestemme sepsis hos mennesker
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200970180A1 (ru) Способ предсказания агрегации белков и конструирования ингибиторов агрегации
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
MA34263B1 (fr) Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs)
DK1625163T3 (da) Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DK2005185T3 (da) Fremgangsmåde til identifikation af polypeptidtargets
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
WO2006124526A3 (en) Method for assessing the effectiveness of a treatment regimen by determining zonulin
HRP20201418T1 (hr) Postupak dijagnoze zaraznog peritonitisa i predviđanje težine i ishoda istog kod ljudi
EA200900714A1 (ru) Датчик ионов для текучей среды и способ его изготовления
WO2010061283A3 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
RU2016141232A (ru) Анализ на гликированные белки
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
BRPI0817393A2 (pt) Anticorpo monoclonal, polipetídeo solúvel isolado, método de inibição do progresso de tumores, método de inibição de emt em células e método de determinação se um tumor reagirá a um antagonista de b2 ou um antagonista de notch
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
DK2274623T3 (da) Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension